Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Inventory (2021 - 2025)

Biote has reported Inventory over the past 5 years, most recently at $19.1 million for Q4 2025.

  • Quarterly results put Inventory at $19.1 million for Q4 2025, up 28.42% from a year ago — trailing twelve months through Dec 2025 was $19.1 million (up 28.42% YoY), and the annual figure for FY2025 was $19.1 million, up 28.42%.
  • Inventory for Q4 2025 was $19.1 million at Biote, up from $16.4 million in the prior quarter.
  • Over the last five years, Inventory for BTMD hit a ceiling of $19.2 million in Q2 2024 and a floor of $7.4 million in Q2 2023.
  • Median Inventory over the past 5 years was $12.8 million (2025), compared with a mean of $13.5 million.
  • Biggest five-year swings in Inventory: soared 159.76% in 2024 and later plummeted 36.85% in 2025.
  • Biote's Inventory stood at $9.6 million in 2021, then increased by 16.31% to $11.2 million in 2022, then soared by 54.76% to $17.3 million in 2023, then fell by 14.23% to $14.8 million in 2024, then grew by 28.42% to $19.1 million in 2025.
  • The last three reported values for Inventory were $19.1 million (Q4 2025), $16.4 million (Q3 2025), and $12.1 million (Q2 2025) per Business Quant data.